Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR: Tamoxifen vs Raloxifene for Breast Cancer Prevention
NCT00003906Phase 3Completed
- Sponsor
- NSABP Foundation
- Start
- May 1999
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of raloxifene in breast cancer, sponsored by NSABP Foundation. Started May 1999; status: completed.
02
Drugs
raloxifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003906.